NCT00334542View on ClinicalTrials.gov

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

November 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

simvastatin

24-28 weeks of simvastatin

Trial Locations (2)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02115-6084

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00334542 - Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer | Biotech Hunter | Biotech Hunter